GPT Healthcare LimitedQ1 FY27 Results & Financial Update
GPT Healthcare Limited: Q1 FY27 standalone results and company financials – revenue ₹126.20 Cr, PAT ₹12.73 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
GPT Healthcare price & chart
Market priceLoading…
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore GPT Healthcare Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
GPT Healthcare Limited reported standalone total income of INR 128.23 crore for the quarter ended June 30, 2026, alongside revenue from operations of INR 126.20 crore. Profit after tax for the period stood at INR 12.73 crore, reflecting basic earnings per share of INR 1.55.
According to the company's investor presentation for Q1 FY27, total revenue grew by 18.0% year-on-year from INR 108.7 crore in Q1 FY26 to INR 128.2 crore, while EBITDA expanded by 38.5% year-on-year to INR 26.2 crore with an EBITDA margin of 20.4%.
Operating performance during the quarter was bolstered by an improvement in the average revenue per occupied bed (ARPOB), which rose to INR 42,350 driven by a favorable clinical mix, enhanced surgical complexity, and operating efficiencies across the network.
Network occupancy stood at 45.5% overall for the quarter, or 58.07% when excluding the newly commissioned Raipur facility. Mature hospitals continued to deliver steady patient footfalls and strong community trust, with individual unit occupancy rates reaching 62.4% at Salt Lake, 65.4% at Dum Dum, and 45.3% at Agartala.
Clinical capabilities across the network were further advanced during the quarter. Salt Lake reinforced its leadership in robotic-assisted surgery with over 800 cumulative procedures, while Howrah commenced MAKO robotic knee replacement surgeries to support higher realisations.
Agartala expanded its oncology platform by integrating PET Scan and Linear Accelerator facilities, completing over 700 radiation therapy procedures. Meanwhile, the newly commissioned Raipur hospital continued its ramp-up in high-acuity specialties including oncology, cardiology, and transplant services.
Cost structures for the quarter included material consumption costs of INR 24.1 crore, employee benefit expenses of INR 23.2 crore, and other expenses of INR 54.6 crore. Depreciation and amortisation expenses were reported at INR 6.88 crore, while finance costs stood at INR 2.16 crore.
01 · Business model
What does GPT Healthcare do?
GPT Healthcare Limited operates a growing hospital platform in Eastern India under the ILS Hospitals brand, running neighborhood tertiary-care facilities located within densely populated residential areas. Its proximity-based model provides patients with accessible medical care while maintaining control over clinical standards and capital returns.
The network covers multiple locations including Salt Lake, Dum Dum, Howrah, Agartala, and Raipur, offering advanced medical capabilities across specialties such as oncology, cardiology, minimally invasive surgery, and renal transplants.
The clinical infrastructure is supported by 719 total beds, 115 full-time consultants, and 630 visiting consultants, alongside integrated diagnostics and NABH and NABL accreditations across key units.
The company follows a capital-efficient operating model, deploying asset-light expansion strategies where real estate is funded by developers under fixed rental arrangements to support long-term return on capital employed.
02 · Historical context
What shaped the business before this quarter
The company established its footprint with the commissioning of Salt Lake Hospital in West Bengal in 2000, subsequently expanding to 719 total operational beds across five hospitals by FY27.
The company commenced operations at its 158-bed quaternary care hospital in Raipur, Chhattisgarh, in May 2025, expanding its geographic reach into Central India.
03 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹126.20 Cr |
| Total income | ₹128.23 Cr |
| Profit before tax | ₹17.16 Cr |
| Profit after tax | ₹12.73 Cr |
| EPS | ₹1.55 |
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Average revenue per occupied bed increased to INR 42,350 in Q1 FY27, supported by an improved clinical mix, advanced surgical procedures, and operating efficiencies.
Growth was driven by higher patient volumes across high-acuity services such as oncology, robotic surgeries, renal transplants, and interventional cardiology.
What drove margins
EBITDA margin improved year-on-year to 20.4% in Q1 FY27 compared to 17.4% in Q1 FY26, aided by better capacity utilisation in mature units and higher-realisation surgical procedures.
Cost of material consumed stood at INR 24.1 crore and employee benefit expenses were INR 23.2 crore, while finance costs remained controlled at INR 2.16 crore.
05 · Demand, customers & order book
Where demand is coming from
Mature hospitals continued to benefit from strong community trust and steady patient footfalls, maintaining robust occupancy in established urban centers.
06 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
Internal medicine and diabetology accounted for 25% of revenue distribution in Q1 FY27, followed by nephrology with renal transplants at 19%, critical care at 16%, and oncology at 13%.
Geography and market mix
Operations remain anchored in Eastern India across West Bengal, Tripura, and Chhattisgarh, with mature units delivering resilient performance and emerging facilities scaling up.
07 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
Total network bed capacity stood at 719 beds with an overall occupancy rate of 45.5% for Q1 FY27, reaching 58.07% when excluding the new Raipur facility.
Q1 FY27 occupancy rates were reported at 62.4% for Salt Lake, 45.3% for Agartala, 65.4% for Dum Dum, 45.2% for Howrah, and 17.4% for Raipur.
Projects, capex and execution
An MoU was signed for a 155-bed facility in Jamshedpur involving an INR 75 crore investment, with targeted commissioning by the end of FY27.
Future expansion in Tier II cities across Uttar Pradesh, Assam, and Odisha will feature land and building funded by developers under fixed rental arrangements.
08 · Strategy & new businesses
How the company is trying to change its growth mix
The company expanded its advanced surgical offerings by introducing MAKO robotic knee replacement surgeries at Howrah, complementing existing robotic procedures at Salt Lake.
The company promoted its SPARSH senior citizen home healthcare plan at an annual fee of INR 500 alongside the ILS-My Health mobile application for digital appointment booking and record access.
09 · Reported developments
What changed operationally
Standalone profit after tax for Q1 FY27 reached INR 12.73 crore, supported by an 18.0% year-on-year increase in total revenue and a 38.5% year-on-year increase in EBITDA.
Agartala successfully launched comprehensive cancer care with PET Scan and Linear Accelerator facilities, becoming the only integrated oncology unit in Tripura.
10 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Capital allocation & funding
The company maintained a strong balance sheet position with a net debt-to-equity ratio of -0.12 as of FY26, supporting capital-efficient expansion.
11 · Management guidance & targets
What management is targeting from here
Management aims to scale network capacity to over 1,000 beds within the next two years through strategic expansion in Tier I and Tier II Eastern India markets.
Management targets maintaining network occupancy at around 70% across mature hospitals and sustaining a long-term ROCE of approximately 25%.
Management stated that the Raipur hospital remains on track to achieve operational breakeven by Q3 FY27.
12 · Beyond the numbers
What changed beyond the numbers
Reported update
Accreditations
Hospitals across the network maintain NABH and NABL accreditations, reinforcing quality compliance and clinical standards.
13 · Key Q&A
The quarter, answered directly
What does GPT Healthcare do?
GPT Healthcare Limited operates a growing hospital platform in Eastern India under the ILS Hospitals brand, running neighborhood tertiary-care facilities located within densely populated residential areas. Its proximity-based model provides patients with accessible medical care while maintaining control over clinical standards and capital returns.
What is the clearest takeaway from Q1 FY27?
GPT Healthcare Limited reported standalone total income of INR 128.23 crore for the quarter ended June 30, 2026, alongside revenue from operations of INR 126.20 crore. Profit after tax for the period stood at INR 12.73 crore, reflecting basic earnings per share of INR 1.55.
What drove revenue or demand?
Average revenue per occupied bed increased to INR 42,350 in Q1 FY27, supported by an improved clinical mix, advanced surgical procedures, and operating efficiencies.
What mattered most for margins or profitability?
EBITDA margin improved year-on-year to 20.4% in Q1 FY27 compared to 17.4% in Q1 FY26, aided by better capacity utilisation in mature units and higher-realisation surgical procedures.
What changed operationally beyond the headline numbers?
Total network bed capacity stood at 719 beds with an overall occupancy rate of 45.5% for Q1 FY27, reaching 58.07% when excluding the new Raipur facility.
What is management guiding or targeting from here?
Management aims to scale network capacity to over 1,000 beds within the next two years through strategic expansion in Tier I and Tier II Eastern India markets.
14 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
15 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Jamshedpur Project Execution: Track progress on the 155-bed Jamshedpur facility toward its targeted commissioning date by the end of FY27.
- 02
Raipur Breakeven Timeline: Monitor the operational ramp-up and progress toward operational breakeven for the Raipur facility by Q3 FY27.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.